Skip to content

Shanghai Mild Cognitive Impairment Cohort Study

Shanghai Cohort Study on Mild Cognitive Impairment for Early Detection of Alzheimer's Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01552265
Enrollment
400
Registered
2012-03-13
Start date
2012-02-29
Completion date
2017-07-31
Last updated
2018-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Keywords

Mild Cognitive Impairment, Alzheimer's Disease

Brief summary

This study was planned 1) to identify individuals with Mild Cognitive Impairment (MCI) who convert to Alzheimer's Disease (AD), and 2) to explore factors associated with the conversion.

Interventions

None listed

Sponsors

Fudan University
CollaboratorOTHER
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Cognitive concern reflecting a change in cognition reported by the patient or informant or clinician 2. Mini-Mental State Examination (MMSE) scores between 18-30 (inclusive) 3. Clinical Dementia Rating (CDR) =0.5; Memory Box score must be at least 0.5 4. Objective memory loss\* as evidenced by Auditory Verbal Learning test (AVLT-HS) 5. Essentially preserved activities of daily living based on Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL) 6. Not-demented, as defined by 'All-cause Dementia (see 3.4. All-cause Dementia) 7. Willing to and able to undergo all test procedures including neuroimaging, and agree to longitudinal follow up 8. Written informed consent for the participation of this study including repeated neuropsychological tests and MRI scans

Design outcomes

Primary

MeasureTime frame
Time to Conversion from MCI to Probable AD Dementia3 years

Secondary

MeasureTime frame
Time to Conversion from MCI to Possible AD Dementia or Probable AD Dementia3 years
Time to Conversion from MCI to All-cause Dementia3 years
Overall survival3 years
Changes in Neuropsychological examinationsbaseline, annual and 3 years
Changes in MRIbaseline, annual and 3 years

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026